Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Malignancy

Malignancy

Part of Cancer

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Malignancy

6 trials tracked for Malignancy: 1 in phase 3 or 4.

6Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 2 2 Phase 1 2 Other / NA 1
  1. Phase 4 Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain Completed
  2. Phase 2 Abatacept as GVHD Prophylaxis Phase 2 Completed
  3. Phase 2 Allogeneic Transplantation From Related Haploidentical Donors Completed
  4. Phase 1 Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors Completed
  5. Phase 1 Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Participants With Solid Tumors Completed
  6. N/A Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Contrast-enhanced mammography shows 97% sensitivity for mammographic asymmetries in meta-analysis
OB/GYN & Women's Health Meta-analysis
Contrast-enhanced mammography shows 97% sensitivity for mammographic asymmetries in meta-analysis Contrast Mammography Shows High Accuracy For Breast Cancer
This meta-analysis of 1266 women with 1328 asymmetries found that contrast-enhanced mammography (CEM) has a pooled sensitivity of 97% and sp…
A new analysis finds contrast-enhanced mammography detects breast cancer with 97% sensitivity, potentially reducing unnecessary biopsies.
Jun 1, 2026
Narrative review on PCSK9 inhibitors for familial hypercholesterolemia
Drug Pipeline Sys. Review
Narrative review on PCSK9 inhibitors for familial hypercholesterolemia Review explores PCSK9 inhibitors for familial hypercholesterolemia
This narrative review synthesizes evidence on PCSK9 inhibitors, including evolocumab, for familial hypercholesterolemia. The authors discuss…
This review looks at PCSK9 inhibitors like evolocumab for people with familial hypercholesterolemia. It discusses how these drugs work and t…
Frontiers May 27, 2026
Combined tumor markers and CT imaging show high sensitivity for solitary pulmonary nodule malignancy
Genetics & Precision Medicine Cohort
Combined tumor markers and CT imaging show high sensitivity for solitary pulmonary nodule malignancy Study finds combining blood tests and CT scans may help assess lung nodule cancer risk
A retrospective cohort study of 110 patients with solitary pulmonary nodules found that combining serum tumor markers (CEA, NSE, CA-125, CYF…
Combining blood tests and CT scans correctly identified 96.9% of cancerous lung nodules, outperforming either test alone in spotting maligna…
Frontiers Apr 3, 2026